Cargando…
Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
BACKGROUND: Estimation of total cardiovascular risk is useful for developing preventive strategies for individual patients. The POWER (Physicians’ Observational Work on Patient Education According to their Vascular Risk) survey, a 6-month, open-label, multinational, post-marketing observational eval...
Autores principales: | Goudev, Assen, Berrou, Jean-Pascal, Pathak, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459724/ https://www.ncbi.nlm.nih.gov/pubmed/23049261 http://dx.doi.org/10.2147/VHRM.S34834 |
Ejemplares similares
-
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
por: Radaideh, Ghazi Ahmad, et al.
Publicado: (2011) -
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
por: Petrella, Robert J, et al.
Publicado: (2015) -
Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey
por: De Backer, Guy, et al.
Publicado: (2013) -
New Insights into the Management of Hypertension and Cardiovascular
Risk with Angiotensin Receptor Blockers: Observational Studies Help Us?
por: Goudev, Assen
Publicado: (2014) -
Effects of Eprosartan on Target Organ Protection
por: de la Sierra, Alejandro
Publicado: (2006)